Viracta Therapeutics, Inc.
VIRXDelisted Jul 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061027
Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Viracta Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +1 vs. Q2 2024
- Shares held
- 5.59M
- −3.15M (−36.1%) vs. Q2 2024
- Total value
- $1.29M
- −$3.46M (−72.8%) vs. Q2 2024
- New holders
- 11
- 6 more added
- Sold out
- 10
- 6 more reduced
3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 7 | $3.80K |
| Q4 2024 | 32 | $583.0K |
| Q3 2024 | 38 | $1.29M |
| Q2 2024 | 40 | $4.91M |
| Q1 2024 | 40 | $9.58M |
| Q4 2023 | 42 | $5.56M |
| Q3 2023 | 42 | $10.1M |
| Q2 2023 | 41 | $14.1M |
| Q1 2023 | 48 | $19.4M |
| Q4 2022 | 56 | $18.1M |
| Q3 2022 | 59 | $52.8M |
| Q2 2022 | 63 | $44.2M |
| Q1 2022 | 69 | $62.2M |
| Q4 2021 | 69 | $51.8M |
| Q3 2021 | 68 | $124.6M |
| Q2 2021 | 63 | $151.8M |
| Q1 2021 | 50 | $92.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Viracta Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 1,520,240 | $351.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 954,485 | $220.5K | 0.00% | −206,795−17.8% | Reduced |
| Samsara BioCapital, LLC | 689,709 | $159.6K | 0.03% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 500,000 | $115.7K | 0.07% | +500,000 | New |
| Laurion Capital Management LP | 332,189 | $76.9K | 0.00% | −75,110−18.4% | Reduced |
| Aisling Capital Management LP | 288,571 | $66.4K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 250,007 | $57.9K | 0.00% | −20,766−7.7% | Reduced |
| Renaissance Technologies LLC | 245,399 | $56.8K | 0.00% | +27,700+12.7% | Added |
| BlackRock, Inc. | 234,846 | $54.3K | 0.00% | +234,846 | New |
| HRT Financial LP | 138,822 | $32.0K | 0.00% | +138,822 | New |
| Landscape Capital Management, L.L.C. | 68,317 | $15.8K | 0.00% | +68,317 | New |
| State Street Corp | 65,867 | $15.2K | 0.00% | 00.0% | Unchanged |
| United Capital Financial Advisers, LLC | 42,995 | $9.89K | 0.00% | +42,995 | New |
| Northern Trust Corp | 38,104 | $8.82K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 30,669 | $7.10K | 0.00% | −103,875−77.2% | Reduced |
| Goldman Sachs Group Inc | 27,090 | $6.27K | 0.00% | +27,090 | New |
| Inspirion Wealth Advisors, LLC | 25,000 | $5.79K | 0.00% | +10,000+66.7% | Added |
| Royal Bank of Canada | 20,000 | $5.00K | 0.00% | +19,543+4,276.4% | Added |
| WealthTrust Axiom LLC | 16,396 | $3.79K | 0.00% | +5,000+43.9% | Added |
| Bank of America Corp | 15,054 | $3.48K | 0.00% | +2,558+20.5% | Added |
| Colony Group, LLC | 14,000 | $3.24K | 0.00% | +14,000 | New |
| Tower Research Capital LLC (TRC) | 13,870 | $3.20K | 0.00% | +1,218+9.6% | Added |
| Trust Co of Toledo NA | 12,317 | $2.85K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 10,174 | $2.35K | 0.00% | −9,027−47.0% | Reduced |
| Acadian Asset Management LLC | 10,908 | $2.00K | 0.00% | 00.0% | Unchanged |
| Planning Capital Management Corp | 7,272 | $1.68K | 0.00% | 00.0% | Unchanged |
| Dunhill Financial, LLC | 5,000 | $1.16K | 0.00% | +5,000 | New |
| RP Management, LLC | 3,700 | $851 | 0.00% | 00.0% | Unchanged |
| IAG Wealth Partners, LLC | 3,000 | $694 | 0.00% | 00.0% | Unchanged |
| Oarsman Capital, Inc. | 1,000 | $231 | 0.00% | +1,000 | New |
| Jones Financial Companies LLLP | 1,000 | $222 | 0.00% | +1,000 | New |
| JPMorgan Chase & Co | 721 | $167 | 0.00% | 00.0% | Unchanged |
| Indiana Trust & Investment Management CO | 200 | $46 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 171 | $40 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 95 | $22 | 0.00% | −1,595−94.4% | Reduced |
| Parallel Advisors, LLC | 8 | $2 | 0.00% | 00.0% | Unchanged |
| Addison Advisors LLC | 4 | $1 | 0.00% | 00.0% | Unchanged |
| Planned Solutions, Inc. | 1 | $0 | 0.00% | +1 | New |
| BVF Inc | 0 | $0 | 0.00% | −3,614,662−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −74,000−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −61,601−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −30,789−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −27,417−100.0% | Sold out |
| Beacon Pointe Advisors, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7,337−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,668−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Hoylecohen, LLC | – | – | – | – | Not filed |
| Private Ocean, LLC | – | – | – | – | Not filed |